Shanxi C&Y Pharmaceutical Group Co Ltd (300254)

Shenzhen

Currency in CNY

12.16

+0.01(+0.08%)

Delayed Data·02:56:39

Fair Value

Unlock Value

Day's Range

12.04

12.23

52 wk Range

7.44

14.23

300254 Financial Summary

A brief financial summary of Shanxi C&Y Pharmaceutical Group Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio81.03

Price/Book10.96

Debt / Equity89.91%

Return on Equity10.4%

Dividend Yield0.00%

EBITDA113.85M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2022

01/01

2023

01/01

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

848.07

930.37

829

799.31

846.61

Gross Profit

aa.aa

583.52

640.32

577.79

539.86

563.39

Operating Income

aa.aa

-198.33

-28.16

-23.64

25.1

62.97

Net Income

aa.aa

-262.37

-91.44

-118.52

25.2

42.19

Balance Sheet

Total Assets

aa.aa

1,800.52

1,526.81

1,584.41

1,433.08

1,547.73

Total Current Liabilities

aa.aa

489.9

400.03

599.68

422.37

570.81

Total Equity

aa.aa

872.61

744.58

729.71

778.43

598.18

Cash Flow

Levered Free Cash Flow

aa.aa

16.84

23.16

316.58

-161.38

52.96

Cash from Operations

aa.aa

-20.88

96.92

74.88

37.81

70.94

Cash from Investing

aa.aa

-5.41

-25.21

-23.2

72.1

-248.27

Cash from Financing

aa.aa

63.33

-152.3

112.56

-241.77

194.84

Net Change in Cash

aa.aa

37.05

-80.58

164.24

-131.85

17.51

* In Millions of CNY (except for per share items)

Earnings

Latest Release

Apr 18, 2025

EPS / Forecast

0.04 / --

Revenue / Forecast

181.74M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Shanxi C&Y Pharma's earnings for the latest quarter?

The Shanxi C&Y Pharma EPS (TTM) is 0.14. Shanxi C&Y Pharma reported sales of 181.74, net income of 10.39, and EPS of 0.04 for the latest quarter.

What was Shanxi C&Y Pharma's net income for the latest quarter?

Shanxi C&Y Pharma's net income for the latest quarter was 10.39.

How did Shanxi C&Y Pharma's performance compare year-over-year in the latest quarter?

The company's revenue moved from 237.79 in the previous quarter to 181.74 in the latest quarter, and net income moved from -1.96 to 10.39 compared to the previous quarter.

What is Shanxi C&Y Pharma's net profit margin on a TTM basis?

Shanxi C&Y Pharma's trailing twelve months (TTM) net profit margin is 4.98%.

How does Shanxi C&Y Pharma's debt to equity ratio compare to industry standards?

Shanxi C&Y Pharma's total debt-to-equity ratio is 89.91%.

What is Shanxi C&Y Pharma's return on investment on a TTM basis?

Shanxi C&Y Pharma's trailing twelve months (TTM) return on investment (ROI) is 10.40%.

Did Shanxi C&Y Pharma gain or lose cash last quarter?

In the latest quarter, Shanxi C&Y Pharma's net change in cash was -62.50 million.

What were Shanxi C&Y Pharma's total assets and liabilities in the latest quarter?

As of the latest quarter, Shanxi C&Y Pharma reported total assets of 1,483.63 million and total liabilities of 466.21 million.

How has Shanxi C&Y Pharma's total revenue grown this year?

Shanxi C&Y Pharma's total revenue was 237.79 in the previous quarter and 181.74 in the latest quarter.

What is Shanxi C&Y Pharma's gross margin on a TTM basis?

Shanxi C&Y Pharma's trailing twelve months (TTM) gross margin is 67.32%.

What was Shanxi C&Y Pharma's revenue per share for the latest quarter?

Shanxi C&Y Pharma's revenue per share for the latest quarter was 6.97.

NSE 30

5,339.18

+30.90

+0.58%

NSE All Share

145,813.86

+1,017.49

+0.70%

US 30

44,267.00

+73.6

+0.17%

US 500

6,365.90

+20.8

+0.33%

FTSE 100

9,164.31

+21.58

+0.24%

DAX

23,924.36

+78.29

+0.33%

South Africa Top 40

92,725.09

+529.59

+0.57%

Market Movers

Name	Last	Chg. %	Vol.
Sterling Bank	8.160	+9.97%	183.77M
Zenith Bank	74.40	-1.98%	60.35M
Access Holdings	27.50	+0.55%	56.24M
UBA	48.10	-1.64%	35.09M
Guaranty Trust Holding	99.40	+0.40%	15.13M
MTN Nigeria	480.00	0.00%	3.82M
Dangote Cement	577.00	0.00%	2.72M

Name	Last	Chg. %	Vol.
SCOA Nigeria	5.500	+10.00%	225.11K
Learn Africa	6.270	+10.00%	1.87M
Meyer	18.15	+10.00%	1.08M
Nem	29.700	+10.00%	460.45K
Mutual Benefits Assurance	2.42	+10.00%	19.25M
Jaiz Bank	4.73	+10.00%	20.48M
Guinness Nigeria	128.75	+10.00%	191.23K

Name	Last	Chg. %	Vol.
UH REIT	57.60	-10.00%	250.19K
Nigerian Exchange	63.00	-10.00%	12.71M
UAC Of Nigeria	90.00	-10.00%	6.94M
Livingtrust Mortgage Bank	5.35	-9.93%	399.81K
Multverse	9.80	-9.68%	565.22K
Rtbriscoe	3.50	-9.09%	947.90K
Initiates	13.00	-7.14%	6.17M

Trending Stocks

Name	Last	Chg. %	Vol.
Aiico	2.90	+9.85%	90.68M
BUA Cement	183.00	+7.33%	4.14M
VFD PLC	13.10	-2.96%	8.65M
Jaiz Bank	4.73	+10.00%	20.48M
MTN Nigeria	480.00	0.00%	3.82M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaa Aaa	577.00	+34.83%	777.97
Aaa Aa	68.00	+22.91%	83.58

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Shanxi C&Y Pharmaceutical Group Co Ltd (300254)

300254 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Shanxi C&Y Pharma's earnings for the latest quarter?

What was Shanxi C&Y Pharma's net income for the latest quarter?

How did Shanxi C&Y Pharma's performance compare year-over-year in the latest quarter?

What is Shanxi C&Y Pharma's net profit margin on a TTM basis?

How does Shanxi C&Y Pharma's debt to equity ratio compare to industry standards?

What is Shanxi C&Y Pharma's return on investment on a TTM basis?

Did Shanxi C&Y Pharma gain or lose cash last quarter?

What were Shanxi C&Y Pharma's total assets and liabilities in the latest quarter?

How has Shanxi C&Y Pharma's total revenue grown this year?

What is Shanxi C&Y Pharma's gross margin on a TTM basis?

What was Shanxi C&Y Pharma's revenue per share for the latest quarter?

Trending Stocks